Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare
Lexicon Pharmaceuticals, Inc. Gross Profit 2009–2025
Lexicon Pharmaceuticals, Inc. annual/quarterly gross profit history and growth rate from 2015 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Lexicon Pharmaceuticals, Inc. gross profit for the quarter ending March 31, 2026 was 21.0 M, a 1604.06% increase year-over-year.
- Lexicon Pharmaceuticals, Inc. gross profit for the twelve months ending March 31, 2026 was 65.2 M, a 1408.58% increase year-over-year.
- Lexicon Pharmaceuticals, Inc. annual gross profit for 2025 was 49.5 M, a 819.76% increase from 2024.
- Lexicon Pharmaceuticals, Inc. annual gross profit for 2024 was 5.4 M, a 425.37% increase from 2023.
- Lexicon Pharmaceuticals, Inc. annual gross profit for 2023 was 1.0 M.
- Lexicon Pharmaceuticals, Inc. annual gross profit for 2022 was 0.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lexicon Pharmaceuticals, Inc. Gross Profit — FAQ
Lexicon Pharmaceuticals, Inc. (LXRX) gross profit over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Lexicon Pharmaceuticals, Inc.'s gross profit?
Lexicon Pharmaceuticals, Inc. (LXRX) reported gross profit of $50M for fiscal 2025.
Where can I see LXRX's gross profit history?
The chart and table above show Lexicon Pharmaceuticals, Inc.'s gross profit by year and by quarter, including the growth rate.